Home Tags Drugs and Pharmaceuticals
Tag: Drugs and Pharmaceuticals
Stem Cell Reviews and Reports Journal: iCell Gene Therapeutics Announces cCAR-T Clinical Publication
STONY BROOK, N.Y. /Massachusetts Newswire - National News/ -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, today announced the publication of their clinical study utilizing cCAR T-cell immunotherapy to successfully treat a patient with lupus.
AUSTIN, Texas /Massachusetts Newswire - National News/ -- Kalyagen® has announced the release and availability of a free eBook, "The Stemregen Effect - Tapping into the Power of Your Own Stem Cells," which provides an overview of how stem cells are the body's repair system and how STEMREGEN®, a natural stem cell enhancer, has been documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).
July 2021 C. diff. Symposium to support and guide patients, families, and caregivers through a C. difficile illness
TAMPA, Fla. /Massachusetts Newswire - National News/ -- The C Diff Foundation will host a free, live-online, and interactive symposium on Friday, July 16, 2021, from 1 to 3 p.m. EDT. Sponsored by Seres Therapeutics, the event is designed for patients who are being treated for a C. diff. infection (CDI) in addition to those who are recovering or who have experienced CDI recurrences.
AUSTIN, Texas /Massachusetts Newswire - National News/ -- Pure MHC, LLC, a target discovery and development company, today announced the launch of its Peptide HLA Immunotherapy Data Resource ("PHIDR"), built through its collaboration with a trusted provider of transplant solutions and a leader in regenerative medicine, LifeNet Health.
Pure Transplant Solutions Collaborates with Univ. of Alabama at Birmingham to Develop Memory B Cell-Directed Diagnostics for HLA-Sensitized Patients
BIRMINGHAM, Ala. /Massachusetts Newswire - National News/ -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with The University of Alabama at Birmingham (UAB), a leading institution in transplant research.
AUSTIN, Texas /Massachusetts Newswire - National News/ -- Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its "Oral Delivery Device and Methods" (US Patent 10238577). This latest patent expands the capabilities of Zeteo's ZEO Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route.
AUSTIN, Texas /Massachusetts Newswire - National News/ -- Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings.
CARY, N.C., Feb. 12, 2021 (SEND2PRESS NEWSWIRE) -- Rescindo Therapeutics Inc., a drug discovery company dedicated to the development of new treatments for rare genetic disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation and Rare Pediatric Disease Designation for the Company's lead drug RSC-57, for the treatment of patients with Kabuki Syndrome.
Kalyagen Announces New ‘Stem the Tide of Time’ Campaign Featuring NBA Hall of Fame Finalist Marques Johnson
AUSTIN, Texas, Feb. 8, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen is pleased to announce the launch of its "Stem the Tide of Time" social media campaign featuring former UCLA Bruin and Milwaukee Buck All-Star Marques Johnson to promote STEMREGEN;, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM). (VIDEO)
SAN FRANCISCO, Calif., Feb. 4, 2021 (SEND2PRESS NEWSWIRE) -- EPIC Holdings, Inc. (EPIC) announced today that it has agreed to acquire Pharmaceutical Strategies Group (PSG). The move incorporates the expertise and resources of the nation's largest independent pharmacy benefit consulting firm into EPIC's Employee Benefits Consulting practice.
Kalyagen Announces Launch of Clinical Trial to Evaluate STEMREGEN and Stem Cells for Heart Failure Patients
AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the "Spanish Society of Regenerative Medicine and Cell Therapy"), is pleased to announce the launch of a multicenter clinical trial, "The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure," to evaluate the use of stem cell therapies in patients suffering from heart failure.
Zeteo Biomedical Collaborates with Iowa State University Nanovaccine Institute to Study a COVID-19 Vaccine Under Fast Track Funded Program
AUSTIN, Texas, Nov. 17, 2020 (SEND2PRESS NEWSWIRE) -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2 Delivery Platform.
CHRISTIANSBURG, Va., Oct. 28, 2020 (SEND2PRESS NEWSWIRE) -- Avila Herbals, a company specializing in novel botanical extraction techniques for both dietary supplements and pharmaceuticals, announced today that it has signed an exclusive global manufacturing agreement and a research and development agreement with Phoenix Biotechnology.
NED Biosystems Announces Infectious Disease Research Scientist Michael Mansour, MD, PhD to Serve as Medical Advisor
CAMBRIDGE, Mass. /Massachusetts Newswire/ -- NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour, MD, PhD, will serve as the Company's Medical Advisor of Infectious Disease.
DECATUR, Ga., Aug. 17, 2020 (SEND2PRESS NEWSWIRE) -- US Pharmaceutical Corporation, the probiotic and nutritional supplement company, launches Hylafem pH vaginal suppositories, a unique, patented, homeopathic suppository product which efficaciously tackles recurring women's vaginal health issues.
PITTSBURGH, Pa., Aug. 17, 2020 (SEND2PRESS NEWSWIRE) -- Thar Process, Inc - an American manufacturer of high-tech supercritical CO2 extraction and purification equipment - is proud to announce the signing of a new exclusive distribution deal with YMC India (a subsidiary of YMC Co. Ltd., JAPAN).
Aristea Translational Medicine Corp. has initiated development of PhenT, a drug with novel cellular protective properties
PARK CITY, Utah, May 26, 2020 (SEND2PRESS NEWSWIRE) -- Silent Hypoxia is a frequent disabling and sometimes fatal complication in COVID-19 disease. To prevent SARS-CoV-2 coronavirus-induced damage to patients' lungs and Silent Hypoxia in patients, Aristea Translational Medicine Corp. has initiated development of PhenT, a drug with novel cellular protective properties.
ROKiT Pharma Preclinical Studies Show Promise for Naturally Derived Cancer Drug, ROK-001 – Moving Towards The Initiation Of Phase 1b/2 Clinical...
LOS ANGELES, Calif., April 2, 2020 (SEND2PRESS NEWSWIRE) -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients.
KENNETT SQUARE, Pa., March 26, 2020 (SEND2PRESS NEWSWIRE) -- Boothwyn Pharmacy, a PCAB-accredited compounding pharmacy located mere minutes from the heart of Kennett Square, Pennsylvania, has dedicated resources to manufacture hand sanitizer.
SAN FRANCISCO, Calif. and NEW YORK, N.Y., Feb. 3, 2020 (SEND2PRESS NEWSWIRE) -- EPIC Insurance Brokers and Consultants, a retail property, casualty insurance brokerage and employee benefits consultant, announced today they are continuing to expand their employee benefits resources with the addition of a new Pharmacy Practice Leader, Bob Eisendrath.
iCell Gene Therapeutics Announces CAR-T Presentations at 61st American Society of Hematology Annual Meeting
STONY BROOK, N.Y., Nov. 14, 2019 (SEND2PRESS NEWSWIRE) -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to be held December 7-10, 2019 in Orlando, Florida.
AMMPA’s 2019 Annual Meeting Hosted Over 300 Attendees and Physicians in the Medical Marijuana Industry
ORLANDO, Fla., Nov. 8, 2019 (SEND2PRESS NEWSWIRE) -- The American Medical Marijuana Physicians Association (AMMPA) held their 3rd Annual Conference on October 4-6 at the Hilton Orlando Lake Buena Vista. More than 300 medical marijuana practitioners and physicians from across the nation and other countries around the world attended the 3-day conference.
C Diff Foundation Raises Clostridioides difficile Awareness at 7th Annual International Conference and Health EXPO
ST. LOUIS, Mo., Oct. 14, 2019 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that the 7th Annual International C. diff. Conference and Health EXPO is honored to welcome over 30 international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies. November 6 - 7, 2019 at the DoubleTree by Hilton Westport Hotel.
LAS VEGAS, Nev., Sept. 11, 2019 (SEND2PRESS NEWSWIRE) -- BioAdaptives, Inc. (OTC BB: BDPT) announced the Company's return to a fully-reporting entity, and the appointment of Mr. Robert W. Ellis as its new President, reporting to Dr. Edward E. Jacobs, Jr.
BOSTON, Mass. /Massachusetts Newswire/ -- The Lupus Research Alliance has awarded its 2019 Lupus Insight Prize to Ignacio Sanz, MD, for discovering that certain little-understood immune system cells are a major source of the harmful proteins that promote lupus symptoms. His work could spark new treatments for the disease and help doctors determine which patients could benefit from current drugs.
NEW PORT RICHEY, Fla., Jan. 29, 2019 (SEND2PRESS NEWSWIRE) -- The C. Diff Foundation Board of Directors announced today that the 2019 "Above and Beyond" Award will be presented to Rebiotix CEO Lee Jones in Roseville, Minnesota. The award, given to one recipient annually, is given to a person or organization that show extraordinary dedication to C. diff patient safety, advocacy, and overall drive to improve the lives of those impacted by the infection.
WESTMONT, Ill., Jan. 15, 2019 (SEND2PRESS NEWSWIRE) -- Pet health products company, Pet King Brands, Inc. - the maker of veterinarian-recommended brands ZYMOX(R) Dermatology and Oratene(R) Brushless Oral Care - celebrates 20 years of helping pets find relief from problematic ear, skin and mouth conditions.
PORTLAND, Ore., Nov. 27, 2018 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck announces holiday event, "A Night to Remember," scheduled Friday, Dec. 7, 2018 from 5:30 - 8 p.m. in Eugene, Ore. The event delivers a magical night of holiday sights and sounds for the families of Pearl Buck Preschool.
Leading Health Companies Support C Diff Foundation 6th Annual International C.diff. Conference, Nov. 8-9 in Philadelphia
PHILADELPHIA, Pa., Oct. 31, 2018 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation is honored to welcome leading companies to the 6th Annual International "C.diff. Awareness Conference and Health EXPO," as they come together to make a global difference. These companies are dedicated to the prevention, diagnostics, treatments, environmental safety products and services focused on C.difficile infections and Healthcare-associated infections and whose role serves great importance in the C.diff. community.
FREMONT, Calif., April 23, 2018 (SEND2PRESS NEWSWIRE) -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, has been named one of the "Top 10 Pharmacy Management Solution Providers of 2018," according to Healthcare Tech Outlook, a digital and print magazine publication of Valley Media, Inc.
PORTLAND, Ore., April 13, 2018 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching or research career in ophthalmology.
C Diff Foundation Presents 2018 Award to CutisPharma in Recognition of Contribution to C. diff. Community
NEW PORT RICHEY, Fla., March 16, 2018 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation announced today that it presented CutisPharma, Inc., its "Making a Difference" award as a special recognition of the significant contribution that CutisPharma has made to the C.diff. Community: helping the advancement of C.diff. awareness as well as expanding treatment options for C.diff. patients.
PITTSBURGH, Pa., Feb. 16, 2018 (SEND2PRESS NEWSWIRE) -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, announces a robust integration with Suncoast by Complia Health, a leading global provider of home health care and hospice software solutions.
NASHVILLE, Tenn., Nov. 2, 2017 (SEND2PRESS NEWSWIRE) -- ScriptDrop, a healthcare technology company providing medication reminders and deliveries while fighting prescription abandonment and abuse, today announced that it will be featured on "The Success Files" hosted by Rob Lowe, airing on PBS in 2018.
Paragon BioTeck Calls Emerging Leaders to Apply for 2018 Ophthalmology Scholarship – the next Koch Kellan Scholar
PORTLAND, Ore., Oct. 2, 2017 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or research career in ophthalmology. A Paragon Gives initiative, the scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs.
Edmond Hooker MD and Bruce Rippe Discuss Medical Mattress Contamination Issues on C.diff Spores and More
TAMPA, Fla., July 31, 2017 (SEND2PRESS NEWSWIRE) -- C Diff Foundation's, "C. diff. Spores and More Global Broadcasting Network," is honored to announce Dr. Edmond Hooker, MD - Associate Professor of Health Services Administration at Xavier University, Darrel Hicks, a well-known hospital environment specialist and educator, and Bruce Rippe, CEO of Trinity Guardion, manufacturer of the Trinity Guardion Patient Protective Barrier, as our guest speakers on August 1, 2017.
SAN DIEGO, Calif., June 12, 2017 (SEND2PRESS NEWSWIRE) -- ChemDiv Inc., a fully integrated California-based CRO, announced today that Arcus Biosciences selected ChemDiv as the sole source of molecules for Arcus's growing HTS screening collection. This collaboration, which utilized Arcus's medicinal chemistry knowledge and ChemDiv's computational and synthetic chemistry expertise, has resulted in the selection of several hundred thousand structures from which Arcus expects to identify starting points for several of the discovery programs in its portfolio.
Verify Smart Corp Signs Letter of Intent to Acquire Equity Stake and International Reseller Rights in Med-Con Technologies, LLC
FERNLEY, Nev., June 8, 2017 (SEND2PRESS NEWSWIRE) -- Verify Smart Corporation (OTC:VSMR / OTCMKTS:VSMR) a Global innovator in financial fraud prevention and digital distribution solutions announced today that it has signed a Letter of Intent to acquire an equity stake and exclusive international reseller rights in Med-Con Technologies, LLC for cash and stock.
Ascende – a Division of EPIC adds Reba Mathew, Pharm.D., R.Ph to Employee Benefits Consulting Pharmacy Practice
SAN FRANCISCO, Calif. and HOUSTON, Texas, May 16, 2017 (SEND2PRESS NEWSWIRE) -- EPIC Insurance Brokers & Consultants, a retail property, casualty insurance brokerage and employee benefits consultant, announced today that Reba Mathew Pharm.D., R.Ph has joined the firm's Employee Benefits Consulting Practice as Pharmacy Practice Director.
IRVING, Texas, April 19, 2017 (SEND2PRESS NEWSWIRE) - BioTE(R) Medical announces a forum of medical experts gathering before the Age Management Medicine Group (AMMG) to form consensus on testosterone therapy in women. The AMMG conference runs April 27-30, 2017 in Orlando, Florida.
PITTSBURGH, Pa., April 18, 2017 (SEND2PRESS NEWSWIRE) -- Delta Care Rx today announced the first-ever recipient of the Delta Distinguished Scholar award. Patrick White, MD, HMDC, FACP, FAAHPM, chief medical officer of BJC Hospice, St. Louis, and assistant professor of medicine at Washington University, has received an initial $25,000 research grant, with a $500,000 lifetime potential, for study into the comparative and cost effectiveness of pharmaceuticals.
CORTE MADERA, Calif., March 31, 2017 (SEND2PRESS NEWSWIRE) -- Dr. Don Harte, chiropractic activist, says Trump's new panel, headed by Chris Christie, to deal with the opioid epidemic, is "philosophically and scientifically dead wrong." Dr. Harte declares, "The reason for this epidemic is clear. Orthopedists and other doctors freely prescribe Oxycontin, Fentanyl, Soma and other opioid drugs, get their patients addicted."
PORTLAND, Ore., Nov. 21, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc. announces a monumental ruling handed down by the United States Patent and Trademark Office (USPTO) affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.
GRAND RAPIDS, Mich., and ZURICH, Switzerland, Sept. 29, 2016 (SEND2PRESS NEWSWIRE) -- eAgile Inc., a global leader in radio frequency identification (RFID) technologies, announces a partnership with Heinlein Plastik-Technik GmbH to bring RFID smart packaging solutions to the European cap and closure marketplace. eSeal is the first turnkey solution engineered to integrate the benefits of RFID into the billions of caps and closures consumed by the over-the-counter pharmaceutical, nutraceutical, cosmetic and chemical manufacturers.
PORTLAND, Ore., Sept. 1, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today a call for applications for the 2017 Koch Kellan Scholarship, awarded annually to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology. A Paragon Gives initiative, the Koch Kellan Scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs and improve the quality of lives around the world.
Pharma companies gain competitive advantage from 1 day Masterclass on Artificial Intelligence in Pharma sales and marketing
NEW YORK, N.Y., Aug. 2, 2016 (SEND2PRESS NEWSWIRE) -- Eularis announces the release of their one-day Masterclass "Using Artificial Intelligence to Transform Sales and Revenue: What Pharma Need to Know." Many Pharma sales and marketing teams do not understand the relevance, nor the critical importance, of AI to achieve stronger results in their roles, and believe it is not relevant to them or their job. This is an incorrect assumption.
SARASOTA, Fla., July 28, 2016 (SEND2PRESS NEWSWIRE) -- The Sarasota Florida attorney commented after a Philadelphia jury returned a verdict of $70 million against Johnson and Johnson for failing to warn of the risks associated for taking Risperdal. The case involved a sixteen-year-old boy who developed breast from the medication prescribed for attention deficit disorder (ADHD).
ATLANTA, Ga., May 11, 2016 (SEND2PRESS NEWSWIRE) -- BioTE(R) Medical, a leader in bioidentical hormone replacement therapy (BHRT), is expanding its nationwide network of certified physicians into the Atlanta, Georgia market this month.
W&L Hopes Faster FDA Publication of Potential Risk Signals for SGLT2 Inhibitors: Newest – Stroke, Thromboembolic Events, Acute Kidney Injury
NEW YORK, N.Y., April 1, 2016 (SEND2PRESS NEWSWIRE) -- Weitz and Luxenberg, P.C., said today it hopes potentially fatal side effects associated with SGLT2 inhibitor drugs will be reported to consumers faster, since people taking these next-generation diabetes medications deserve to be notified of the health dangers shortly after they have been reported to the U.S. Food and Drug Administration (FDA).
PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company's successful implementation of an effective quality management system.
GRAND RAPIDS, Mich. and ZURICH, Switzerland, Jan. 26, 2016 (SEND2PRESS NEWSWIRE) -- eAgile Inc., a global leader in radio frequency identification (RFID) technologies, announces the successful high-volume production launch of the eSeal heat induction solution. eSeal is the first turnkey solution engineered to integrate the benefits of RFID into the billions of caps and closures consumed by the over-the-counter pharmaceutical, nutraceutical, cosmetic and chemical manufacturers.
IRVING, Texas, Dec. 30, 2015 (SEND2PRESS NEWSWIRE) -- A current BioTE(R) Medical Combat Trauma Treatment Study (in conjunction with the Veterans Advocacy Center (VAC)) is showing promising results in helping veterans suffering from Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI).
NEW YORK, N.Y., Feb. 11, 2015 (SEND2PRESS NEWSWIRE) -- Ellen Relkin, of counsel attorney with Weitz and Luxenberg, P.C., has been named to the plaintiffs' steering committee created by judicial order to facilitate lawsuits against the makers of the anticoagulant drug Xarelto, the personal injury and mass tort law firm today announced.